BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27262172)

  • 1. A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair Deficiencies.
    Zhang Y; Fox JT; Park YU; Elliott G; Rai G; Cai M; Sakamuru S; Huang R; Xia M; Lee K; Jeon MH; Mathew BP; Park HD; Edelmann W; Park CY; Hong SY; Maloney D; Myung K
    Cancer Res; 2016 Jul; 76(14):4183-91. PubMed ID: 27262172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells.
    Guillotin D; Austin P; Begum R; Freitas MO; Merve A; Brend T; Short S; Marino S; Martin SA
    Clin Cancer Res; 2017 Jun; 23(11):2880-2890. PubMed ID: 27913567
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
    Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
    Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).
    Leenders EKSM; Westdorp H; Brüggemann RJ; Loeffen J; Kratz C; Burn J; Hoogerbrugge N; Jongmans MCJ
    Eur J Hum Genet; 2018 Oct; 26(10):1417-1423. PubMed ID: 29904176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
    Yang JL; Qu XJ; Yu Y; Kohn EC; Friedlander ML
    Int J Cancer; 2008 Jul; 123(2):258-263. PubMed ID: 18464258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 8. Baicalein Induces G
    Chuang TC; Shao WS; Hsu SC; Lee SL; Kao MC; Wang V
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.
    Sawant A; Kothandapani A; Zhitkovich A; Sobol RW; Patrick SM
    DNA Repair (Amst); 2015 Nov; 35():126-36. PubMed ID: 26519826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines.
    Chang DK; Goel A; Ricciardiello L; Lee DH; Chang CL; Carethers JM; Boland CR
    Cancer Lett; 2003 Jun; 195(2):243-51. PubMed ID: 12767533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into protein - DNA interactions, stability and allosteric communications: a computational study of mutSα-DNA recognition complexes.
    Negureanu L; Salsbury FR
    J Biomol Struct Dyn; 2012; 29(4):757-76. PubMed ID: 22208277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhodium Complexes Targeting DNA Mismatches as a Basis for New Therapeutics in Cancers Deficient in Mismatch Repair.
    Nano A; Dai J; Bailis JM; Barton JK
    Biochemistry; 2021 Jul; 60(26):2055-2063. PubMed ID: 34115466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.
    Berera S; Koru-Sengul T; Miao F; Carrasquillo O; Nadji M; Zhang Y; Hosein PJ; McCauley JL; Abreu MT; Sussman DA
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1163-71. PubMed ID: 27046481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity.
    Christmann M; Tomicic MT; Kaina B
    Nucleic Acids Res; 2002 May; 30(9):1959-66. PubMed ID: 11972333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MutSα maintains the mismatch repair capability by inhibiting PCNA unloading.
    Kawasoe Y; Tsurimoto T; Nakagawa T; Masukata H; Takahashi TS
    Elife; 2016 Jul; 5():. PubMed ID: 27402201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.
    Adamson AW; Beardsley DI; Kim WJ; Gao Y; Baskaran R; Brown KD
    Mol Biol Cell; 2005 Mar; 16(3):1513-26. PubMed ID: 15647386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion and Binding of Mismatch Repair Protein, MSH2, in Breast Cancer Cells at Different Stages of Neoplastic Transformation.
    Sigley J; Jarzen J; Scarpinato K; Guthold M; Pu T; Nelli D; Low J; Bonin K
    PLoS One; 2017; 12(1):e0170414. PubMed ID: 28125613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors?
    Lin AY; Lin E
    J Hematol Oncol; 2015 Nov; 8():124. PubMed ID: 26542241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.